Nicholas Magnus (CPR&D, Eli Lilly and Company)
"Glucokinase Activator - Type 2 Diabetes: Development of an Enantioselective Hydrogenation Based Process"
Calendars
- All Events
- Biochemistry Seminar
- Biophysics Seminar
- (CBBI) Chemistry, Biochemistry, Biology Interface Program
- Departmental Colloquium
- Heidelberg at Notre Dame
- IMPACT Lecture Series
- Inorganic Seminar
- J.P. Freeman Lectureship
- Nieuwland Lecture
- Organic Seminar
- Physical/Analytical Seminar
- Reilly Lecture
- Special Seminar